Introduction

In pharmacovigilance (PV), data is the foundation of all safety-related decisions. From individual case safety reports (ICSRs) to aggregate safety evaluations, regulatory actions, and benefit–risk assessments, the reliability of outcomes depends entirely on the integrity of the underlying data.

Data integrity in PV systems ensures that safety information is accurate, complete, consistent, and reliable throughout its lifecycle. In an increasingly digital and global PV environment, maintaining data integrity is both a regulatory expectation and a critical component of patient safety.

This brief overview explores the core principles of data integrity in PV systems, key roles and responsibilities, regulatory expectations, and practical controls to ensure compliance.

Understanding Data Integrity in PV

Data integrity refers to the assurance that data is complete, consistent, accurate, and trustworthy throughout its entire lifecycle—from initial receipt and entry, through processing and analysis, to reporting and archiving.

In pharmacovigilance, data integrity applies to:

– Individual Case Safety Reports (ICSRs)

– Safety databases and validated PV systems

– Source documents and supporting evidence

– Regulatory submissions and safety communications

Why Data Integrity Matters in Pharmacovigilance

Data integrity failures in PV can have serious consequences, including:

– Delayed detection of safety signals

– Incorrect benefit–risk evaluations

– Inaccurate regulatory submissions

– Regulatory findings, inspections observations, or sanctions

– Potential risks to patient safety

Regulatory authorities expect Marketing Authorization Holders (MAHs) to demonstrate that their PV data can be relied upon to support timely and scientifically sound safety decisions. As PV activities are often outsourced or shared across global networks, maintaining robust data integrity controls is more critical than ever.

Roles and Responsibilities in Ensuring Data Integrity

Marketing Authorization Holder (MAH)

The MAH holds ultimate responsibility for data integrity within the PV system. This includes:

– Establishing and maintaining a compliant PV system

– Ensuring validated safety databases are in place

– Defining clear procedures for data handling and documentation

– Overseeing vendors and service providers involved in PV activities

Qualified Person for Pharmacovigilance (QPPV)

QPPV plays a central oversight role by:

– Ensuring the PV system operates in compliance with regulatory requirements

– Overseeing data quality and integrity processes

– Escalating data integrity issues that may impact patient safety or compliance

– Ensuring corrective and preventive actions (CAPAs) are implemented when needed

PV Staff and Service Providers

All personnel involved in PV activities are responsible for:

– Accurate and timely data entry and processing

– Adhering to standard operating procedures (SOPs)

– Maintaining traceability and documentation

 – Reporting errors, deviations, or system issues promptly

Regulatory Expectations and Guidance

Global regulatory authorities emphasize data integrity as a core element of PV compliance. Key expectations include:

• EU GVP Modules (particularly Module I): Require PV systems to ensure data quality, traceability, and auditability
• ICH Guidelines: Support consistent data handling and reporting standards across regions
• National regulations: Often reinforce requirements for validated systems, controlled access, and proper documentation

During PV inspections and audits, authorities typically assess:

– Data flow from source to submission

 – System access controls and user roles

– Audit trails and change management

– SOPs governing data entry, review, and reporting

– Training records and staff competency

– Records management.

Key Controls to Maintain Data Integrity in PV Systems

Effective data integrity is supported by a combination of technical, procedural, and organizational controls, including:

• Validated PV systems with documented lifecycle management
• Role-based access controls to prevent unauthorized data changes
• Audit trails that record who did what and when
• Clear SOPs covering case intake, data entry, quality checks, and reporting
• Regular quality reviews and reconciliations
• Training and awareness programs focused on data integrity principles
• Vendor oversight and audits for outsourced PV activities

Proactive monitoring and continuous improvement are essential to identify and mitigate data integrity risks before they impact compliance or patient safety.

Data Integrity in a Digital and Global PV Environment

With increasing automation, electronic reporting, and global data exchange, PV systems face new data integrity challenges, such as:

– Interface errors between systems

– Inconsistent data standards across regions

– Reliance on third-party vendors and cloud-based solutions

Organizations must ensure that digital transformation in PV is accompanied by strong governance, validation, and oversight to preserve data reliability and regulatory confidence.

Key Takeaways

• Data integrity is fundamental to effective pharmacovigilance and patient safety
• ALCOA+ principles provide a practical framework for ensuring reliable PV data
• The MAH retains ultimate responsibility for data integrity within the PV system
• QPPVs and PV staff play critical roles in oversight, execution, and continuous monitoring
• Regulators closely scrutinize data integrity during PV inspections
• Robust systems, procedures, training, and vendor oversight are essential to maintain compliance